Publication | Closed Access
Reversible cerebral vasoconstriction syndrome in association with fingolimod use
13
Citations
6
References
2016
Year
Fingolimod has the potential to cause vasoconstriction however appears to be rare and more likely on doses higher than 0.5 mg daily. Fingolimod may be associated in RCVS and should be considered in patients with severe headache on fingolimod.
| Year | Citations | |
|---|---|---|
Page 1
Page 1